BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Immunoglobulin Class Switching

Below is an extended Immunoglobulin Class Switching research listing. Click here to return to the Immunoglobulin Class Switching main in depth entry.

Recent Publications on Immunoglobulin Class Switching:

IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. 20th August, 2008
Immunology and Inflammation Group, Garvan Institute of Medical Research,
The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice. 20th August, 2008
Division of Rheumatology and Immunology, Department of Medicine, Medical
A fundamental role for interleukin-21 in the generation of T follicular helper cells.
T cell help to B cells is a fundamental property of adaptive immunity, yet...
Direct Link
13th August, 2008
Department of Immunology, Garvan Institute of Medical Research, 384
Regulation of B cell tolerance by 129-derived chromosome 1 loci in C57BL/6 mice.
OBJECTIVE: Systemic lupus erythematosus is a multifactorial disease with a...
Direct Link
9th August, 2008
Molecular Genetics and Rheumatology Section, Faculty of Medicine, Imperial
Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. 29th July, 2008
Department of Pathology and Laboratory Medicine, Weill Graduate School of
A role for DRAK2 in the germinal center reaction and the antibody response.
DAP-related apoptotic kinase-2 (DRAK2), a death-associated protein kinase...
Direct Link
22nd July, 2008
Center for Immunology, University of California, Irvine, CA, USA.
MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation.
MicroRNAs (miRNAs) are small noncoding RNAs that regulate vast networks of...
Direct Link
8th July, 2008
Laboratory of Molecular Immunology, The Rockefeller University, New York,
MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase.
B lymphocytes perform somatic hypermutation and class-switch recombination...
Direct Link
8th July, 2008
Laboratory of Lymphocyte Biology, The Rockefeller University, 1230 York
Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma.
Primary lymphomas of the CNS (PCNSLs) show molecular features of the late...
Direct Link
4th July, 2008
Department of Neuropathology, University Hospital of Cologne, Kerpener
Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. 2nd July, 2008
Department of Microbiology and Immunology, University of Miami, Miller
B-cell maturation defects in common variable immunodeficiency and association with clinical features.
AIMS: Patients with common variable immunodeficiency (CVID) often have...
Direct Link
25th June, 2008
Institute of Clinical Pathology and Medical Research, Westmead Hospital,
The regulation of IgA class switching.
IgA class switching is the process whereby B cells acquire the expression...
Direct Link
18th June, 2008
Department of Pathology and Laboratory Medicine, Weill Medical College of
Detection of isotype switch rearrangement in bulk culture by PCR.
When a B lymphocyte changes from synthesizing IgM to synthesizing IgG,...
Direct Link
18th June, 2008
Center for Biologics Evaluation and Research, Food and Drug
Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma.
We report a case of a previously healthy 31 year old woman diagnosed with...
Direct Link
3rd June, 2008
University of Rochester, Hematology/Oncology, Rochester, New York 14642,
Control of IL-4 expression in T helper 1 and 2 cells.
The mechanism of differentiation of naive T cells to a variety of effector...
Direct Link
16th May, 2008
King's College London, MRC and Asthma UK Centre in Allergic Mechanisms of
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional